icd 9 code for lambda light chain disease

by Kellie Mante 3 min read

2011 ICD-9-CM Diagnosis Code 790.99 : Other abnormal findings on examination of blood.

What is the ICD 10 code for light chain amyloidosis?

Light chain (AL) amyloidosis 1 E85.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM E85.81 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of E85.81 - other international versions of ICD-10 E85.81 may differ. More ...

What is light chain deposition disease (LCDD)?

Summary Light chain deposition disease (LCDD) is a rare condition characterized by the deposition of specific proteins (monoclonal light chains) in the kidneys and other organs. Light chains are used to make antibodies that the body needs to fight infection.

What are the signs and symptoms of light chain disease?

Signs and symptoms. Light chains may be deposited in many other organs and may or may not result in any symptoms. Other than the kidneys, liver and heart are the most commonly involved organs. Deposition of light chains in the liver may lead to hepatomegaly, an enlarged liver, or rarely portal hypertension or liver failure.

What are the treatment options for light chain disease (LCD)?

The goal of treating LCDD is to slow the production of light chains and their damage to organs. Treatment may include chemotherapy with a drug called Bortezomib; autologous stem cell transplantation; immunomodulatory drugs; and/or kidney transplant. If untreated, end-stage renal disease occurs in 70% of cases.

image

What is the ICD-10 code for light chain disease?

ICD-10 code E85. 81 for Light chain (AL) amyloidosis is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .

What is the ICD-10 code for kappa light chain disease?

E85. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What is the ICD-10 code for IGG Kappa?

ICD-10 | Monoclonal gammopathy (D47. 2)

What is the ICD 9 code for CBC and CMP?

2013 ICD-9-CM Diagnosis Code 790.99 : Other nonspecific findings on examination of blood.

What is lambda light chain disease?

Light chain myeloma can be classified as lambda or kappa light chain myeloma, depending on which type the cancerous cells produce. These light chains can build up in the kidneys, nerves, or other organs and cause serious complications. These two types of proteins have different structures.

What is kappa and lambda light chain?

Light chains are proteins produced by immune cells called plasma cells. Also called kappa and lambda light chains, they link together with other proteins (heavy chains) to form immunoglobulins (also known as antibodies) that target and neutralize specific threats to the body such as bacteria and viruses.

What is the ICD-10 code for lambda myeloma chain?

Multiple myeloma not having achieved remission C90. 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C90. 00 became effective on October 1, 2021.

What does high free kappa and lambda light chains mean?

Kappa Free Light Chain Test. A kappa free light chain test is a blood test that checks for high levels of certain proteins in your blood. Elevated free light chains might mean you have a plasma cell disorder.

What is kappa light chain?

Light chain deposition disease (LCDD) is a rare condition characterized by the deposition of specific proteins (monoclonal light chains) in the kidneys and other organs. Light chains are used to make antibodies that the body needs to fight infection.

What ICD code is R79 89?

Other specified abnormal findings of blood chemistryICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .

What ICD-10 code will cover CMP?

Encounter for screening for other metabolic disorders The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.

What is R79 89 diagnosis?

R79. 89 - Other specified abnormal findings of blood chemistry. ICD-10-CM.

What is a light chain deposition disease?

Light chain deposition disease ( LCDD) is a rare blood cell disease which is characterized by deposition of fragments of infection-fighting immunoglobulins, called light chains (LCs), in the body. LCs are normally cleared by the kidneys, but in LCDD, these light chain deposits damage organs ...

Where are light chains deposited in LCDD?

Unlike in AL amyloidosis, in which light chains are laid down in characteristic amyloid deposits, in LCDD, light chains are deposited in non-amyloid granules.

What happens if you have light chain deposition?

About half of people with light chain deposition disease also have a plasma cell dyscrasia, a spectrum of diseases that includes multiple myeloma, Waldenström's macroglobulinemia, and the monoclonal gammopathy of undetermined significance premalignant stages ...

image

Overview

Light chain deposition disease (LCDD) is a rare blood cell disease which is characterized by deposition of fragments of infection-fighting immunoglobulins, called light chains (LCs), in the body. LCs are normally cleared by the kidneys, but in LCDD, these light chain deposits damage organs and cause disease. The kidneys are almost always affected and this often leads to kidney failure. About half of people with light chain deposition disease also have a plasma cell dyscrasia, …

Signs and symptoms

The kidney is the organ most frequently affected. Proteinuria, the presence of protein in the urine, is characteristic. More than 90% of people with LCDD develop kidney failure, often with rapid progression of disease.
Light chains may be deposited in many other organs and may or may not result in any symptoms. Other than the kidneys, liver and heart are the most commonly involved organs. Deposition of lig…

Diagnosis

A number of laboratory tests are required in order to assist in diagnosing LCDD. Blood and urine samples are collected for evaluation of kidney and liver function and determination of the presence of a monoclonal protein. Imaging studies such as echocardiography and an ultrasound of the abdomen will be performed. A CT scan, magnetic resonance imaging (MRI) or positron emission tomography (PET) may also be indicated. In patients with LCDD, a biopsy of the affected organ wi…

Treatment

Decreasing production of the organ-damaging light chains is the treatment goal. Options include chemotherapy using bortezomib, autologous stem cell transplantation, immunomodulatory drugs, and kidney transplant. There is no standard treatment for LCDD. High-dose melphalan in conjunction with autologous stem cell transplantation has been used in some patients. A regimen of bortezomib and dexamethasone has also been examined.

Prognosis

The median time to progression to end stage renal disease is 2.7 years. After 5 years, about 37% of patients with LCDD are alive and do not have end stage renal disease.

External links

• National Institutes of Health Genetic and Rare Diseases Information Center
• Emedicine